A Randomized Trial of Frovatriptan for the Intermittent Prevention of Menstrual Migraine

NCT00644033 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

579

Enrollment

INDUSTRY

Sponsor class

Conditions

Menstrually Associated Migraine

Interventions

DRUG: Frovatriptan
DRUG: Frovatriptan
DRUG: Placebo

Sponsor

Endo Pharmaceuticals

Collaborators

[object Object]